
### [MONDO:0016345](http://purl.obolibrary.org/obo/MONDO_0016345)
**Label:** non-familial restrictive cardiomyopathy

**Subclasses:** [MONDO:0019438](http://purl.obolibrary.org/obo/MONDO_0019438) (AL amyloidosis), [MONDO:0008418](http://purl.obolibrary.org/obo/MONDO_0008418) (scleroderma, familial progressive), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0019564](http://purl.obolibrary.org/obo/MONDO_0019564) (systemic sclerosis), [MONDO:0015691](http://purl.obolibrary.org/obo/MONDO_0015691) (hypereosinophilic syndrome), [MONDO:0017834](http://purl.obolibrary.org/obo/MONDO_0017834) (secondary hypereosinophilic syndrome), 

**Corr. equiv. classes:** [Orphanet:168956](http://www.orpha.net/ORDO/Orphanet_168956), [Orphanet:90291](http://www.orpha.net/ORDO/Orphanet_90291), [OMIM:181750](http://purl.obolibrary.org/obo/OMIM_181750), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [Orphanet:85443](http://www.orpha.net/ORDO/Orphanet_85443), [Orphanet:314962](http://www.orpha.net/ORDO/Orphanet_314962), 

**Class expressions from DL-Learner:**

- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0100533](http://purl.obolibrary.org/obo/HP_0100533) (Inflammatory abnormality of the eye) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0030956](http://purl.obolibrary.org/obo/HP_0030956) (Abnormality of cardiovascular system electrophysiology) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0025337](http://purl.obolibrary.org/obo/HP_0025337) (Red eye) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0011675](http://purl.obolibrary.org/obo/HP_0011675) (Arrhythmia) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0011495](http://purl.obolibrary.org/obo/HP_0011495) (Abnormality of corneal epithelium) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0011277](http://purl.obolibrary.org/obo/HP_0011277) (Abnormality of the urinary system physiology) 66.67%
- [HP:0002781](http://purl.obolibrary.org/obo/HP_0002781) (Upper airway obstruction) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) 66.67%


